Where a transgene integrates can influence its expression, creating variability between independently generated cell lines and making direct comparisons more difficult.
Rouken’s proprietary LocIn technology uses a defined genomic landing pad and site-specific integration to place new genetic material at the same genomic location. A unique two-step selection strategy selects successfully integrated cells and removes non-targeted platform cells, enabling 100% re-targeting of the selected population without conventional single-cell subcloning.
With ready-to-use HEK293 and CHO-K1 platform cell lines, LocIn can generate stable, re-targeted cell populations in as little as 12 days. The same platform can also be repeatedly re-targeted with different genes or variants, creating highly comparable isogenic cell models for screening and biological research.
Explore the science behind LocIn, its two-step selection system, and how targeted integration can make stable cell line generation faster and more consistent.
Discover LocIn technology →